Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
2,047
-78
-4% -$36K 0.01% 422
2026
Q1
$1.02M Sell
2,125
-2
-0.1% -$1.02K 0.02% 422
2025
Q4
$1.19M Sell
2,127
-415
-16% -$236K 0.02% 397
2025
Q3
$1.31M Buy
2,542
+20
+0.8% +$8.73K 0.02% 405
2025
Q2
$792K Sell
2,522
-91
-3% -$27.3K 0.01% 478
2025
Q1
$796K Sell
2,613
-4,106
-61% -$1.38M 0.01% 465
2024
Q4
$2.36M Sell
6,719
-1,124
-14% -$381K 0.04% 314
2024
Q3
$2.65M Sell
7,843
-746
-9% -$283K 0.05% 289
2024
Q2
$3.54M Buy
+8,589
New +$3.4M 0.06% 258
2023
Q3
Sell
-447
Closed -$107K 1239
2023
Q2
$107K Sell
447
-77
-15% -$16K ﹤0.01% 712
2023
Q1
$98.5K Sell
524
-474
-47% -$98K ﹤0.01% 755
2022
Q4
$212K Buy
+998
New +$199K ﹤0.01% 839
2022
Q2
Sell
-1,231
Closed -$201K 943
2022
Q1
$201K Buy
1,231
+55
+5% +$9.07K ﹤0.01% 931
2021
Q4
$256K Sell
1,176
-34
-3% -$7.12K ﹤0.01% 873
2021
Q3
$229K Buy
+1,210
New +$221K ﹤0.01% 890

Other funds holding MEDP

BOK Financial's MEDP Position: Q2 2026 in Review

BOK Financial reduced its Medpace (MEDP) stake by 3.7% in Q2 2026, selling an estimated $36K and leaving 2,047 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #422.

BOK Financial first reported a position in MEDP in Q3 2021 and has held it in 15 quarters since. The position peaked at $3.54M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • BOK Financial held 2,047 shares of Medpace worth $1.08M as of Q2 2026.
  • BOK Financial sold 78 Medpace shares in Q2 2026, an estimated $36K.
  • Medpace made up 0.01% of BOK Financial's portfolio in Q2 2026, its #422 holding.
  • BOK Financial first reported a position in Medpace in Q3 2021 and has held it in 15 quarters since.
  • BOK Financial's Medpace position peaked at $3.54M in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.